{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:29:28Z","timestamp":1790659768664,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009248","name":"Innovatiefonds Zorgverzekeraars","doi-asserted-by":"publisher","award":["3.048"],"award-info":[{"award-number":["3.048"]}],"id":[{"id":"10.13039\/501100009248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Discontinuing antidepressant medication (ADM) can be challenging for patients and clinicians. In the current study we investigated if Mindfulness-Based Cognitive Therapy (MBCT) added to supported protocolized discontinuation (SPD) is more effective than SPD alone to help patients discontinue ADM. This study describes a prospective, cluster-randomized controlled trial (completed). From 151 invited primary care practices in the Netherlands, 36 (24%) were willing to participate and randomly allocated to SPD+MBCT (k = 20) or SPD (k = 16). Adults using ADM &gt; 9 months were invited by GPs to discuss tapering, followed by either MBCT+SPD, or SPD alone. Exclusion criteria included current psychiatric treatment; substance use disorder; non-psychiatric indication for ADM; attended MBCT within past 5 years; cognitive barriers. From the approximately 3000 invited patients, 276 responded, 119 participated in the interventions and 92 completed all assessments. All patients were offered a decision aid and a personalized tapering schedule (with GP). MBCT consisted of eight group sessions of 2.5 hours and one full day of practice. SPD was optional and consisted of consultations with a mental health assistant. Patients were assessed at baseline and 6, 9 and 12 months follow-up, non-blinded. In line with our protocol, primary outcome was full discontinuation of ADM within 6 months. Secondary outcomes were depression, anxiety, withdrawal symptoms, rumination, well-being, mindfulness skills, and self-compassion. Patients allocated to SPD + MBCT (n = 73) were not significantly more successful in discontinuing (44%) than those allocated to SPD (n = 46; 33%), OR 1.60, 95% CI 0.73 to 3.49, p = .24, number needed to treat = 9. Only 20\/73 allocated to MBCT (27%) completed MBCT. No serious adverse events were reported. In conclusion, we were unable to demonstrate a significant benefit of adding MBCT to SPD to support discontinuation in general practice. Actual participation in patient-tailored interventions was low, both for practices and for patients. (Trial registration: ClinicalTrials.gov PRS ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03361514\" xlink:type=\"simple\">NCT03361514<\/jats:ext-link> registered December 2017)<\/jats:p>","DOI":"10.1371\/journal.pone.0290965","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:27:26Z","timestamp":1693934846000},"page":"e0290965","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice"],"prefix":"10.1371","volume":"18","author":[{"given":"Marloes J.","family":"Huijbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien","family":"Wentink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.B.J.","family":"Lucassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Kramers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Spijker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.M.","family":"Speckens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"pone.0290965.ref001","doi-asserted-by":"crossref","first-page":"f7261","DOI":"10.1136\/bmj.f7261","article-title":"Antidepressant use has doubled in rich nations in past 10 years","volume":"347","author":"M. McCarthy","year":"2013","journal-title":"BMJ"},{"key":"pone.0290965.ref002","unstructured":"Foundation of Pharmaceutical Statistics. Facts and figures 2014. On pharmaceutical care in The Netherlands. 2014."},{"issue":"1","key":"pone.0290965.ref003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bcp.14475","article-title":"Strategies to reduce use of antidepressants","volume":"87","author":"T. Kendrick","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"604","key":"pone.0290965.ref004","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.3399\/bjgp12X658304","article-title":"Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study","volume":"62","author":"CF Johnson","year":"2012","journal-title":"Br J Gen Pract"},{"issue":"2","key":"pone.0290965.ref005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4088\/JCP.13m08443","article-title":"National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey","volume":"75","author":"R Mojtabai","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"pone.0290965.ref006","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.focus.16407","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"16","author":"A Cipriani","year":"2018","journal-title":"Focus"},{"issue":"3","key":"pone.0290965.ref007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.13r08722","article-title":"Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration","volume":"75","author":"S Borges","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"pone.0290965.ref008","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","article-title":"Side effects of antidepressants during long-term use in a naturalistic setting","volume":"23","author":"PM Bet","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"pone.0290965.ref009","first-page":"22","article-title":"SSRI Antidepressant Medications: Adverse Effects and Tolerability","volume":"3","author":"JM Ferguson","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"pone.0290965.ref010","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"C Coupland","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"pone.0290965.ref011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000110056","article-title":"Continuation and maintenance use of antidepressants in recurrent depression","volume":"77","author":"CL Bockting","year":"2008","journal-title":"Psychother Psychosom"},{"issue":"6","key":"pone.0290965.ref012","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review.","volume":"74","author":"RK McHugh","year":"2013","journal-title":"The Journal of clinical psychiatry"},{"key":"pone.0290965.ref013","unstructured":"National Collaborating Centre for Mental Health. The treatment and management of depression in adults (Updated edition) National Clinical Practice Guideline 90. London: The British Psychological Society and The Royal College of Psychiatrists. 2010."},{"key":"pone.0290965.ref014","first-page":"152","volume-title":"Practice Guideline for the Treatment of Patients with Major Depressive Disorder","author":"American Psychiatric Association (APA)","year":"2010","edition":"3"},{"key":"pone.0290965.ref015","volume-title":"Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. Clinical Guidelines for the Management of Anxiety: Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalised Anxiety Disorder) in Adults in Primary, Secondary and Community Care","author":"National Institute for Health and Clinical Excellence","year":"2004"},{"issue":"2","key":"pone.0290965.ref016","first-page":"133","article-title":"Better safe than sorry\u2014why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study","volume":"2","author":"PM Verbeek-Heida","year":"2006","journal-title":"Chronic Illn"},{"issue":"6","key":"pone.0290965.ref017","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/fampra\/cmm069","article-title":"A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors","volume":"24","author":"GM Leydon","year":"2007","journal-title":"Fam Pract"},{"issue":"651","key":"pone.0290965.ref018","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.3399\/bjgp16X686641","article-title":"Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care","volume":"66","author":"RC Bosman","year":"2016","journal-title":"Br J Gen Pract"},{"key":"pone.0290965.ref019","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320933404","article-title":"Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations","volume":"10","author":"W Scholten","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"pone.0290965.ref020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2018.10.107","article-title":"Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis","volume":"245","author":"E Maund","year":"2019","journal-title":"J Affect Disord"},{"key":"pone.0290965.ref021","unstructured":"National Institute for Health and Care Excellence. Depression in adults: recognition and management. CG90. London: NICE; 2009."},{"issue":"4","key":"pone.0290965.ref022","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00228-005-0921-x","article-title":"Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation","volume":"61","author":"EC van Geffen","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"pone.0290965.ref023","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00023210-200620080-00005","article-title":"Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome","volume":"20","author":"A Himei","year":"2006","journal-title":"CNS Drugs"},{"issue":"6","key":"pone.0290965.ref024","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"MA Horowitz","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"pone.0290965.ref025","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320954609","article-title":"Outcome of antidepressant drug discontinuation with taperingstrips after 1\u20135 years","volume":"10","author":"PC Groot","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"pone.0290965.ref026","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320980573","article-title":"Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum","volume":"10","author":"MP Hengartner","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"pone.0290965.ref027","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320921694","article-title":"How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding","volume":"10","author":"MP Hengartner","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"pone.0290965.ref028","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1370\/afm.2336","article-title":"Managing Antidepressant Discontinuation: A Systematic Review","volume":"17","author":"E Maund","year":"2019","journal-title":"Ann Fam Med"},{"key":"pone.0290965.ref029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?","volume":"97","author":"J Davies","year":"2019","journal-title":"Addict Behav"},{"issue":"688","key":"pone.0290965.ref030","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.3399\/bjgp19X706001","article-title":"Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care","volume":"69","author":"C Wentink","year":"2019","journal-title":"British Journal of General Practice"},{"key":"pone.0290965.ref031","article-title":"Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis","author":"JJ Breedvelt","year":"2021","journal-title":"JAMA psychiatry"},{"issue":"2","key":"pone.0290965.ref032","doi-asserted-by":"crossref","first-page":"e033892","DOI":"10.1136\/bmjopen-2019-033892","article-title":"Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies","volume":"10","author":"A Tickell","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0290965.ref033","unstructured":"Segal, Williams JMG, Teasdale JD. Mindfulness-Based Cognitive Therapy for Depression, 2nd edn.: Guilford Press; 2012."},{"issue":"6","key":"pone.0290965.ref034","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamapsychiatry.2016.0076","article-title":"Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials","volume":"73","author":"W Kuyken","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"9988","key":"pone.0290965.ref035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(14)62222-4","article-title":"Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial","volume":"386","author":"W Kuyken","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"pone.0290965.ref036","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1037\/a0013786","article-title":"Mindfulness-based cognitive therapy to prevent relapse in recurrent depression","volume":"76","author":"W Kuyken","year":"2008","journal-title":"J Consult Clin Psychol"},{"issue":"12","key":"pone.0290965.ref037","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archgenpsychiatry.2010.168","article-title":"Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression","volume":"67","author":"ZV Segal","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"pone.0290965.ref038","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.bp.115.168971","article-title":"Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial","volume":"208","author":"MJ Huijbers","year":"2016","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"pone.0290965.ref039","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12875-019-0989-5","article-title":"Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial","volume":"20","author":"C Wentink","year":"2019","journal-title":"BMC Fam Pract"},{"key":"pone.0290965.ref040","doi-asserted-by":"crossref","unstructured":"First MB, Gibbon M, Spitzer RL, Williams JB. User\u2019s guide for the structured clinical interview for DSM-IV axis I Disorders\u2014Research version. New York: Biometrics Research Department, New York State Psychiatric Institute. 1996.","DOI":"10.1037\/t07827-000"},{"issue":"6","key":"pone.0290965.ref041","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/1073191113490790","article-title":"Development and validation of the mindfulness-based interventions \u2010 teaching assessment criteria (MBI:TAC)","volume":"20","author":"RS Crane","year":"2013","journal-title":"Assessment"},{"issue":"20","key":"pone.0290965.ref042","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"DV Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"pone.0290965.ref043","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): Psychometric properties","volume":"26","author":"AJ Rush","year":"1996","journal-title":"Psychol Med"},{"issue":"1","key":"pone.0290965.ref044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation","volume":"34","author":"MH Trivedi","year":"2004","journal-title":"Psychol Med"},{"issue":"2","key":"pone.0290965.ref045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"JF Rosenbaum","year":"1998","journal-title":"Biol Psychiatry"},{"key":"pone.0290965.ref046","article-title":"Assessment of state and trait anxiety: Conceptual and methodological issues","author":"CD Spielberger","year":"1985","journal-title":"Southern Psychologist"},{"issue":"3","key":"pone.0290965.ref047","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1023910315561","article-title":"Rumination reconsidered: A psychometric analysis","volume":"27","author":"W Treynor","year":"2003","journal-title":"Cognitive therapy and research"},{"issue":"1","key":"pone.0290965.ref048","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jclp.20741","article-title":"Evaluating the psychometric properties of the Mental Health Continuum-Short Form (MHC-SF)","volume":"67","author":"SM Lamers","year":"2011","journal-title":"J Clin Psychol"},{"issue":"3","key":"pone.0290965.ref049","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1073191111408231","article-title":"Psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form","volume":"18","author":"E Bohlmeijer","year":"2011","journal-title":"Assessment"},{"issue":"3","key":"pone.0290965.ref050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cpp.702","article-title":"Construction and factorial validation of a short form of the Self-Compassion Scale","volume":"18","author":"F Raes","year":"2011","journal-title":"Clin Psychol Psychother"},{"issue":"2","key":"pone.0290965.ref051","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/fampra\/17.2.192","article-title":"Analysis of cluster randomized trials in primary care: a practical approach","volume":"17","author":"MK Campbell","year":"2000","journal-title":"Fam Pract"},{"key":"pone.0290965.ref052","author":"A Donner","year":"2000","journal-title":"Design and analysis of cluster randomization trials in health research"},{"key":"pone.0290965.ref053","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpsychires.2021.07.043","article-title":"Putting mindfulness-based cognitive therapy to the test in routine clinical practice: A transdiagnostic panacea or a disorder specific intervention?","volume":"142","author":"DEM Geurts","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"2","key":"pone.0290965.ref054","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12671-018-1087-9","article-title":"The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services","volume":"11","author":"A Tickell","year":"2020","journal-title":"Mindfulness (N Y)"},{"issue":"2","key":"pone.0290965.ref055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12671-021-01794-3","article-title":"The Effectiveness of Mindfulness-Based Cognitive Therapy in Primary Care and the Role of Depression Severity and Treatment Attendance","volume":"13","author":"M Elices","year":"2022","journal-title":"Mindfulness (N Y)"},{"issue":"4","key":"pone.0290965.ref056","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen17X101265","article-title":"Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care","volume":"1","author":"R Eveleigh","year":"2018","journal-title":"BJGP open"},{"key":"pone.0290965.ref057","article-title":"Engagement in Prescription Opioid Tapering Research: the EMPOWER Study and a Coproduction Model of Success","author":"A Mardian","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"3","key":"pone.0290965.ref058","doi-asserted-by":"crossref","first-page":"e032312","DOI":"10.1136\/bmjopen-2019-032312","article-title":"Supporting antidepressant discontinuation: the development and optimisation of a digital intervention for patients in UK primary care using a theory, evidence and person-based approach","volume":"10","author":"HM Bowers","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0290965.ref059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04338-7","article-title":"REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial","volume":"21","author":"T Kendrick","year":"2020","journal-title":"Trials"},{"issue":"11","key":"pone.0290965.ref060","doi-asserted-by":"crossref","first-page":"e039053","DOI":"10.1136\/bmjopen-2020-039053","article-title":"Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers","volume":"10","author":"MJ Huijbers","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"pone.0290965.ref061","doi-asserted-by":"crossref","first-page":"e052547","DOI":"10.1136\/bmjopen-2021-052547","article-title":"Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review","volume":"11","author":"A Coe","year":"2021","journal-title":"BMJ Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:27:50Z","timestamp":1693934870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290965"}},"subtitle":[],"editor":[{"given":"Jan Christopher","family":"Cwik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0290965","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}